MET is a gene that encodes a receptor tyrosine kinase that is activated upon binding with hepatocyte growth factor (HGF, or Scatter Factor). Specifically, MET is a Continue reading
MET – an ideal target for antibody drug conjugate therapy, plus nivolumab
Leave a reply